Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a.
about
CD72 negatively regulates KIT-mediated responses in human mast cellsCD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infectionHuman CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cellsCD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell linesThe CD300 molecules: an emerging family of regulators of the immune system.Functional requirements for inhibitory signal transmission by the immunomodulatory receptor CD300a.Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis.Transcriptional profiling of human monocytes identifies the inhibitory receptor CD300a as regulator of transendothelial migration.Peripheral CD300a+CD8+ T lymphocytes with a distinct cytotoxic molecular signature increase in pregnant women with chronic chorioamnionitis.Suppression of CD300A inhibits the growth of diffuse large B-cell lymphoma.Regulation of allergic inflammatory responses by inhibitory receptors.Novel identified receptors on mast cells.Mast cells in asthma--state of the art.All-trans-retinoic acid and Erk1/2 signaling synergistically regulate the expression of CD300B in human monocytic cells.Histamine Release from Mast Cells and Basophils.Identification of CD300a as a new hypoxia-inducible gene and a regulator of CCL20 and VEGF production by human monocytes and macrophages.Human eosinophils and mast cells: Birds of a feather flock together.Expressions and inhibitory functions of CD300a receptors on purified human basophilsCD300a is expressed on human basophils and seems to inhibit IgE/FcεRI-dependent anaphylactic degranulation
P2860
Q24297400-8EEFABE4-8F11-4F87-A9A6-FD8DF82BC744Q24299547-18B8F243-7A26-4C2C-8C49-DA4860A9DAC8Q24304296-E2BD7871-FBBE-43AB-BF66-AC94534AA34CQ28115250-7AFF196B-A503-4BC9-A3AF-F7C84F9C4473Q34035020-5A4FB04D-BDF9-470A-A210-63AE2875F17DQ34248446-294D2860-FAAC-44E4-B6EA-5FB01E2A2B70Q34495630-3B820849-3728-4A7D-8632-F54AB1DBCEC5Q34994488-692D78E9-4BCD-42EF-95B0-284CCE959EA5Q36342271-50371271-3F91-433F-9992-98D4D63F6987Q36544524-B36592EA-0E8D-4B16-BF0A-9DA48800DB00Q37743626-9A826838-CF4C-42DF-90C8-011C1C4A0DEEQ38033164-752FB573-3ACF-46C4-AA8D-56EAE451FADCQ38633155-0E3F66C8-B752-4EE4-8CDB-225E8945AD7BQ39568220-6EDE3659-5D3C-48C2-BDC0-67610902E875Q40282553-7548484C-77D0-441B-BB8D-6D076E0B2683Q44759466-3745A407-7127-4D71-852D-8B7EEE40E856Q50068947-752506C5-4892-49E6-A8D8-C5E830A55876Q58617062-F59EEC73-CA57-475C-B729-5DF539F797C0Q58617073-5F51E28B-C513-4951-B3CF-1331E75B9553
P2860
Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Suppression of normal and mali ...... ibody linking kit with CD300a.
@ast
Suppression of normal and mali ...... ibody linking kit with CD300a.
@en
Suppression of normal and mali ...... ibody linking kit with CD300a.
@nl
type
label
Suppression of normal and mali ...... ibody linking kit with CD300a.
@ast
Suppression of normal and mali ...... ibody linking kit with CD300a.
@en
Suppression of normal and mali ...... ibody linking kit with CD300a.
@nl
prefLabel
Suppression of normal and mali ...... ibody linking kit with CD300a.
@ast
Suppression of normal and mali ...... ibody linking kit with CD300a.
@en
Suppression of normal and mali ...... ibody linking kit with CD300a.
@nl
P2093
P1476
Suppression of normal and mali ...... ibody linking kit with CD300a.
@en
P2093
Ariel Munitz
Beata Berent-Maoz
David Mankuta
Francesca Levi-Schaffer
Ido Bachelet
P304
P356
10.4049/JIMMUNOL.180.9.6064
P407
P577
2008-05-01T00:00:00Z